Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(13/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(13/week)
News
United States
(631/week)
Manufacturing
(426/week)
Energy
(356/week)
Technology
(446/week)
Other Manufacturing
(359/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Glucosides
Jun 18, 2020
Nephrologists Are Hesitant to Fully Embrace Janssen's INVOKANA Despite Being the First and Only SGLT2 Inhibitor with an FDA Indication to Treat Diabetic Kidney Disease
May 05, 2020
FDA approves new treatment for a type of heart failure
Nov 04, 2019
Boehringer Ingelheim and Lilly modernise alliance to focus full expertise on Jardiance®
Sep 30, 2019
FDA Approves New Drug to Treat Diabetes-Related Kidney Disease
Jun 11, 2019
Canagliflozin Shown to Improve Cardiovascular and Renal Outcomes in People with Type 2 Diabetes and Kidney Disease
Jun 10, 2019
Sihuan's Abstracts regarding Clinical Trial Progress of SGLT-2 Inhibitor Selected for Poster Presentation at the American Diabetes Association's Scientific Sessions
Mar 28, 2019
Janssen Submits Supplemental New Drug Application to U.S. FDA for INVOKANA® (canagliflozin) for the Treatment of Chronic Kidney Disease in Patients with Type 2 Diabetes
Nov 10, 2018
Forxiga significantly reduced hospitalisation for heart failure or CV death in a broad patient population with type-2 diabetes in the landmark DECLARE-TIMI 58 trial
May 24, 2018
New Review of the Real-world Data on the Cardiovascular Benefits Associated with the Use of Sodium-glucose Cotransporter 2 Inhibitors - touchENDOCRINOLOGY
Jan 02, 2018
Lawsuits Filed Against J&J Related to its Drug Invokana
Nov 17, 2017
New Real-World Analysis Shows INVOKANA® (canagliflozin) and Other SGLT2 Inhibitors Reduced the Risk of Death and Cardiovascular Events Compared to Other Diabetes Medicines
Sep 18, 2017
Stevioside Market in China 2017-2022 - Research and Markets
Sep 12, 2017
Jardiance® (empagliflozin) tablets reduced risk of cardiovascular death in people with type 2 diabetes and established cardiovascular disease independent of background blood sugar control
Latest News
May 10, 2024
Sherritt Announces Voting Results of its 2024 Annual Meeting of Shareholders
May 10, 2024
Pembina Pipeline Corporation Reports Strong Results for the First Quarter 2024 and Raises Quarterly Common...
May 10, 2024
AEye Announces Partnership with Leading Automotive Electronics and Vision Solutions Provider, LITEON
May 10, 2024
Microvast Reports First Quarter 2024 Financial Results
May 10, 2024
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Both Recommend that SilverBow Resources...
May 10, 2024
Geospace Technologies Corporation Reports Second Quarter and Six-Month 2024 Earnings
May 10, 2024
Alcoa Corporation Declares Quarterly Cash Dividend
May 10, 2024
Murphy USA Inc. Announces Dividend Increase
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events